Meetings

 
 
Code of Ethics
Meetings
CPD
Publications
Links
Membership Application
 
HOME
 
 

Annual Scientific Conference and AGM, 2005

This year the Annual Scientific Conference and Annual General Meeting will be held in Melbourne.  This is a joint IAP Australia and IAP New Zealand meeting.  The major sponsor of the meeting is Bristol-Myers Squibb Pharmaceuticals.

With the list of eminent speakers who are leaders in their field, this will be a very exciting conference. The speakers cover areas of  Biological Psychiatry, Psychotherapy and provision of psychiatric services now and into the future.

Further details regarding  Registration and Accommodation will be posted as they progress.  The early-bird discount ends on 15th October, so send in your registration now.

For any enquiries, please e-mail to   conference05@iap.org.au.


 
Theme: Future Perspectives in Psychiatry
Date 11 - 13 November
Venue: Duxton Hotel, Flinders St, Melbourne

 


Programme in Brief
 

**STOP PRESS**

Arrangement now available to attend just Dr de Jong's Lecture and Workshop for A$150.00.  This includes the Sunday lunch.

For the whole of Sunday, registration is A$200.00

E-mail conference05@iap.org.au to register.

 
Friday:  
7-9 pm Registrations & Cocktails

Saturday
 
9.00am Opening Address
9.10 Dr C Castles
10.00 Professor P Sachdev
10.45 Morning Tea
11.15 Dr Anne Noonan et al
12.15 Assoc Prof T Norman
1.00pm Lunch
2.00 IAP AGM / Free Arvo
7.30pm Conference Dinner

Sunday
 
9.00am Dr D Lubman
9.45 Professor D Copolov
10.45 Morning Tea
11.15 Dr J Grigor
12noon Dr E de Jong
1.00pm Lunch
2.00 SPECT Workshop
4.00 Goodbye
   

Click here to book accomodation
 


Click here for Registration
 Form and Programme
(148kb pdf file)


Click on icon to download free Adobe Reader to open file

 

 

2006 Meetings

41st Congress of the Royal Australian and New Zealand College of Psychiatrists

"Emotional Compass: Navigating Wellbeing"

Sunday 28 May, 2006 - Thursday 1 June, 2006

Perth Convention and Exhibition Centre, Western Australia

The program has a number of invited overseas and binational speakers including Professor German Berrios, Dr Jonothan Chick, Professor Robert Cloninger, Dr Jeremy Holmes.

The emotional compass will be explored across the course of development in the child, adolescent, adult and older adult streams.

 


Speakers

 

Professor Perminder Sachdev

Talk: Enhancing the Human Brain

There is an increasing interest in the development of new technologies to treat or compensate for cognitive, sensory and emotional deficits.  Some of these technologies are being developed to enhance these abilities in otherwise healthy individuals.

Recent research has shed new insights into the plasticity of the human brain and the importance of gene-environmental interaction for its optimal development.  Strategies can therefore be proposed for the nurturing of the developing as well as the adult brain. 

Technologies are also becoming available for therapeutic intervention and even augmentation.  In particular, neuroceuticals (cogniceuticals, emoticeuticals and sensoceuticals) are being developed for mass consumption. 

Direct brain intervention such as TMS, VNS and DBS are coming into frequent use.  The advances in machine-brain interface threaten to blur the boundaries between humans and machines.  These new developments raise social and ethical issues: Will they be safe?  Will they lead to a weakening of personhood and society?  Will they lead to greater inequity?  Will they be misused by the military?  How will society control these new developments?

Bio:
Professor of Neuropsychiatry, University of New South Wales & Clinical Director, Neuropsychiatric Institute, The Prince of Wales Hospitals.  Internationally recognised teacher, researcher and author of papers and books.

 
Dr Dan Lubman

Talk: Substance Use and Psychosis

Dr Dan Lubman is Senior Lecturer in Addiction Psychiatry at the University of Melbourne.

He heads the Substance Use Research and Recovery Focussed (SURRF) Program at ORYGEN Research Centre, where he leads a clinical research team focussed on investigating substance use and comorbidity in youth. This includes a number of pharmacological and psychological treatment trials in psychosis and depression, as well as epidemiological studies of comorbidity amongst psychiatric and substance-using populations.

In collaboration with key youth drug and alcohol agencies in Melbourne, he is currently developing a number of innovative cross-sectorial clinical programs addressing comorbidity and inhalant use in young people. In addition, his research team is exploring neurobiological mechanisms underpinning addiction, utilising neuropsychological, electrophysiological and neuroimaging techniques. This includes an exploration of the impact of substance use on adolescent brain development.


 
Dr Ernst de Jong

Talk:
"To get it right for the patient - is the history really enough?"

Dr Ernst de Jong is a child and adult psychiatrist in private practice in Perth, WA.  He trained in Western Australia as well as in the Netherlands.  

He has been pioneering SPECT imaging as a tool in the evaluation of psychiatric disorders in Perth. Recently Dr de Jong was instrumental in organising, in collaboration with Dr Joe Cardaci, Nuclear Physician and Dr John Clarkson,General Practitioner, the first Australian Course in SPECT imaging for psychiatrists and interested Family Physicians.

New developments in the imaging software for SPECT imaging and high resolution scanners have assisted in the evaluation of complex psychiatric disorders including Mood Disorders and Traumatic Brain Injury.

His talk will explore the value of SPECT imaging in the treatment of psychiatric patients.

 
Dr Anne Noonan

Talk: Seeking solutions: The Practice of Psychiatry in Central Australia - a panel presentation


Dr Noonan is a Consultant Psychiatrist and Jungian analyst with a  keen interest in the indigenous culture of Central and Western Papua.

She and her IAP colleagues, Dr Heiti Muul, Dr Carey Breakey, Dr Goulnara Sowman, who work in Alice Springs and Darwin will make a panel presentation of their work in these areas of the northern Territory. This continues the thread of IAP's interest and presentations in transcultural psychiatry over the last 7 years.

Dr Carole Castles

Talk: Bridging the Gap: The Role of ACPM in provision of community mental health service


Dr Castle
is the current President of the Australian College of Psychological Medicine. She would like to see a future where skilled practitioners could practice good clinical care without sacrificing security of income or trying to jam the management of complex patients into unrealistic time constraints.  Her long-term aim is to see primary care mental health practice recognised, appropriately funded and supported as part of a seamless community based mental health service.

After 19 years in the Army, Carole completed her Master of Psychological Medicine in 2001, since which she has been working in psychotherapy and injury rehabilitation for the Australian Defence Force in Canberra. 

 

 

Dr John Grigor

Talk: Gestalt of Suicide in New Zealand

John is currently working as the Transcultural Psychiatrist with the Capital and Coast District Health Board in Wellington, in services dedicated to Maori and to Pacific Islanders.. Two years ago he ended 5 years as an acute inpatient consultant at Wellington Hospital and has watched, with fascination, the evolving policies surrounding acute inpatient care following an incident where a patient left hospital and climbed into a tiger's cage at the nearby Zoo. The media has maintained a close watch on all incidents since then and this has reshaped patient care in a risk aversive service.

This will be contrasted by Andy Aston, Clinical Director in a nearby District Health Board where this media focus is more benign and the newspapers kept informed.

John has a background, in Victoria, of Administration and Forensic Psychiatry and has been associated with the Richmond Fellowship for 35 years and the Schizophrenia Fellowship for over 20 years. These days he makes training videos and is heavily involved in General Practitioner education.
 
Dr Andy Aston

Trained in Birmingham UK; emigrated to New Zealand in 1987; specialist since 1988.
Clinical Director and Director of Area Mental Health Services since 2002 in Palmerston North New Zealand. Involves activities at Ministry, Local & Regional level. Aspires to help build and sustain an excellent mental health service integrated with other providers and to develop new local services in line with international trends. President (current) of IAPNZ 4+ years.
 
Associate Professor Trevor Norman

Talk: Neurogenesis and Antidepressant Drug Action


Professor Norman is an Associate Professor in the Dept of Psychiatry, University of Melbourne, Austin Hospital campus, where he leads a psychopharmacological research programme encompassing both pre-clinical and clinical research in stress, anxiety and depression.  In addition, he is actively involved in teaching medical and psychological undergraduates and post-graduate trainees in psychiatry.

He holds positions in national and international psychopharmacological  bodies. He has published widely.  He serves on the editorial boards of leading journals in his field.
Professor David Copolov

Talk: Demise of the Specialist Psychiatric Hospital -
        Enlightened Culling or Ideology Driven Vandalism?

Professor Copolov is a Professor of Psychiatry at Monash University, Honorary Professor at the University of Melbourne and Research Group Leader at the Mental Health Research Institute. He is also Senior Advisor – Special Initiatives at Monash University, working closely with the Vice Chancellor’s Group and focusing on major growth strategies for the University.

He was the Director of the Mental Health Research Institute of Victoria from 1985 - 2004 and was responsible for building it from a small unit of the State Health Department into the largest dedicated psychiatric research centre in Australia.

He was a key advocate for the establishment of the Australian National Health and Medical Research Council's Network for Brain Research into Mental Disorders in 1994, and served as the Chief Investigator of the Program. He was also co-Director of the Australian National Health and Medical Research Council's Schizophrenia Research Unit from 1988-1996.

Professor Copolov's research interests have focused on the phenomenology, neuroendocrinology and neurochemistry of schizophrenia, with a particular interest in the pathophysiology of auditory hallucinations.
 

 

This meeting is sponsored by Bristol-Myers Squibb Pharmaceuticals.
 




updated:7 Nov 05